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Metastasis is the major cause of breast cancer lethality. In 
target organs, a series of events are required for the 
establishment of metastatic tumor cells. These events 
include: adherence to the blood vessel, extravasation, 
survival, establishment of micrometastases, and persis­
tent growth into macrometastases. While tumor cell 
intrinsic factors can enhance metastatic efficiency and 
site selection [1], metastasis also relies on interactions 
between spreading tumor cells and host factors in the 
target organ [2]. These host factors include cytokines/
growth factors, extracellular matrix, platelets, and differ­
ent stromal and immune cells [2]. Particularly, a popula­
tion of metastasis­associated macrophages has been 
identified that promotes breast cancer metastasis [3]. 
These cells, derived from a subset of inflammatory mono­
cytic precursor cells, promote tumor cell extravasation 
through vascular endothelial growth factor production 
and their subsequent survival and growth [3,4].
Chen and colleagues have provided a new mechanism 
for the metastasis­promoting function of metastasis­
asso ciated macrophages through their adherence to 
tumor cells that provides survival signals to the tumor 
cells [5]. Previous studies from this group compared gene 
expression changes of subclones of a human mammary 
carcinoma cell line, MDA­MB­231, which have differ en­
tial metastatic efficiencies to target organs when 
introduced into the circulation of immune­deficient mice 
[6]. The hypothesis being that certain genes are 
prefer entially expressed by cells with higher metastatic 
effici ency and that if their expression is correlated with 
poor prognosis and metastatic disease, this gene is likely 
to contribute to the metastatic process in patients. Based 
on this idea, a lung metastasis gene expression signature 
was identified by comparing subclones selected for lung 
metastasis with the parental MDA­MB­231 line and 
those subclones selected for metastasis to bone or brain 
[6]. The focus of the current study by Chen and colleagues 
was vascular cell adhesion molecule­1 (VCAM­1), one of 
the upregulated genes from this lung signature. VCAM­1 
is a cell–cell adhesion protein that binds to α4­integrins 
(α4β1 or α4β7). During inflam mation, α4­integrins 
expressed by leukocytes interact with VCAM­1 in the 
endothelium, which promotes leuko cyte recruitment. 
Such α4­integrin–VCAM­1 interaction also plays impor­
tant roles in recruiting and maintaining hemato poietic 
stem and progenitor cells in the bone marrow [7].
Chen and colleagues showed that the VCAM­1 on 
tumor cells did not enhance tumor transendothelial 
migration and had no effect on the early recruitment of 
immune cells including macrophages. VCAM­1 inter­
actions were thus not important for tumor arrest or extra­
vasation. Instead, VCAM­1 enhanced longer­term tumor 
cell survival and growth of lung meta stases through 
interaction with α4­integrin expressed by meta stasis­
associated macrophages (Figure 1). This cell–cell adhesion 
provides survival signals to the tumor cells by clustering 
of the cell surface VCAM­1. Through its cyto plasmic 
domain, clustered VCAM­1 recruited phos phory lated 
ezrin – which in turn recruits phosphoinositide­3­kinase 
and activates Akt that provides the survival signal in the 
tumor cell. VCAM­1 also supported the re­seeding of 
metastatic cells from the lung into the primary tumor in a 
process known as self­seeding previously described by 
this group [8]. The study also showed that high levels of 
VCAM­1 correlate with increased leukocyte infiltration 
in the primary tumors from breast cancer patients. 
VCAM­1 expressions were also elevated in breast cancer 
metastases to lung and bone, but not in those to brain, 
and high levels of VCAM­1 correlated with tumors with 
high leukocytic infiltration. However, VCAM­1 over­
expression did not enhance metastasis of MDA­MB­231 
cells to the bone. In summary, the results of Chen and 
colleagues establish that metastasis­associated macrophages 
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Recent studies on breast cancer lung metastasis have 
identified a new mechanism of tumor cell survival 
via signaling provided by metastasis-associated 
macrophages. Targeting these specialized host 
immune cells and their specific signals provides an 
attractive and potential therapeutic approach for 
treating the disease.
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provide survival and growth signals to metastatic tumor 
cells through direct binding of α4­integrin to VCAM­1 
expressed by tumor cells.
Using a different line of dormant breast tumor cells, 
another recent study showed that VCAM­1 enhanced the 
propagation of tumor cells in the bone through osteoclast 
activation [9]. This may suggest cell­line­specific mecha­
nisms of VCAM­1 in bone metastasis. Given the critical 
role of VCAM­1 in maintaining hematopoietic stem cells 
[7], direct targeting of this molecule should be taken with 
caution. However, it is attractive to target metastasis­
associated macrophages and their interaction with tumor 
cells to treat metastatic disease. Specific mechanisms that 
control the recruitment and tumor­promoting functions 
of these cells need to be identified to develop novel 
therapeutic approaches for use alone or in combination 
with conventional treatments that target tumor cells. 
Such strategies may provide effective therapies for the 
treatment of metastatic disease.
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Figure 1. Macrophages provide survival signals to metastatic 
tumor cells. VCAM-1 expressed upon metastatic tumor cells 
engages α4β1 or α4β7 integrins on metastasis-associated 
macrophages. This engagement results in VCAM-1 clustering 
that confers a survival signal to the tumor cell and thereby its 
establishment in the metastatic site. VCAM-1, vascular cell adhesion 
molecule-1.
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